Analysis of FDA assessment consideration on cannabidiol indicated for refractory epilepsy
GUAN Hong-feng
LIU Li-hua
DA Hong-yuan
ZHANG Yong-wen
Machine-generated Keywords：
Publication Date：2020-05-15
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：6( 987-992 )